CleanPlex® SARS-CoV-2 Panel
For Research Use Only. Not for use in diagnostic procedures.
CleanPlex® SARS-CoV-2 Panel for sequencing the whole genome of SARS-CoV-2 (the virus responsible for COVID-19) on Illumina Sequencing platform.
The panels are designed to obtain complete viral genomes even from samples with very low SARS-CoV-2 viral content.
Targeted Sequencing NGS Panels to Support SARS-CoV- 2 Research and Surveillance
Superb Performance
Prepare high-quality NGS libraries with excellent on-target performance using CleanPlex Technology to enable efficient use of sequencing reads. CleanPlex panels’ on-target rates are usually much higher than those of hybrid captured-based small target enrichment panels.
Fast, Streamlined Workflow
Generate sequencing-ready libraries in just 5.5 hours using a rapid, four-step protocol including RT step with minimal hands-on time.
High Coverage of Target Regions
Whole-genome coverage of the SARS-CoV-2 genome and selective coverage of influenza and RSV gene segments for sub-typing
Sensitive Detection
Can detect down to 1 copy with high confidence compared 3-5 copies by RT-qPCR (1)
Significant Cost Savings
99% reduction in sequencing cost. Only 30K–50K reads per sample required v.s. 10M reads required by many metagenomics sequencing methods.
Specifications
SKU
Description
Pack Size
SKU
Description
Pack Size
918010
CleanPlex® SARS-CoV-2 Panel
8 reactions
SKU
Description
Pack Size
918011
CleanPlex® SARS-CoV-2 Panel
96 reactions
SKU
Description
Pack Size
918010
CleanPlex® SARS-CoV-2 Panel
384 reactions
SKU
Description
Pack Size
716006
CleanPlex® Dual-Indexed PCR Primers for Illumina® Set A (12 x 8 indexes, 96 reactions)
96
Your content has been submitted